Global Health Progress supports continued protection for pharmaceutical intellectual property rights.
Recently, The Department of Industrial Policy and Promotion (DIPP) distributed a discussion paper speculating how India's compulsory licensing policy impacts the market-availability of low-price life saving drugs. Upon completion of this paper, DIPP requested comments and suggestions from various st...
